No valuation for Cascade Pharma is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($217.6M) and the funding record below are the closest available signals.
- ·The complete investor list: 24 names
- ·Watch Cascade Pharma: the Monday email on marks, rounds and moves
Cascade Pharma funding history
No funding rounds for Cascade Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
How Cascade Pharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Cascade Pharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Cascade Pharma
- How much has Cascade Pharma raised?
- Cascade Pharma has raised $217.6M in total funding across its recorded rounds.